While we focused our phenotyping studies predominately on mice homozygous for the GBA1 D409V KI mutation, we also investigated effects in mice heterozygous for the same mutation to interrogate potential gene dosing effects and because PD patients with GBA1 mutations are typically heterozygous. Here, GBA1 is linked to Parkinson disease.